About Studienpraxis Urologie
"Klinische Forschung, kontrollierte experimentelle Therapie, Herr Prof. Dr. Tilman Todenhöfer und Frau Dr. Susan Feyerabend"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Pfizer
4
Clovis Oncology, Inc.
3
Merck Sharp & Dohme LLC
3
Eli Lilly and Company
2
Ferring Pharmaceuticals
2
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
1
Basilea Pharmaceutica
1
Bavarian Nordic
1
Bayer
1
BioNTech SE
1
Clinical Trials at Studienpraxis Urologie
During the past decade, Studienpraxis Urologie conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 9 clinical trials were completed, i.e. on
average, 34.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2011-11-28
2017-12-15
Completed
1,297
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
2011-04-01
2014-07-01
Completed
180
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
2014-05-26
2020-01-28
Completed
1,182
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
2017-02-15
2021-07-27
Completed
277
Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel
2017-05-05
2021-12-02
Completed
196
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
2017-06-13
2023-03-01
Active, not recruiting
405
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Studienpraxis Urologie" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Pfizer" with 4 trials
sponsored, "Clovis Oncology, Inc." with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored and "Eli Lilly and Company"
with 3 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Studienpraxis Urologie"
#1 collaborator was "Foundation Medicine" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "Janssen Pharmaceutica N.V., Belgium" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Studienpraxis Urologie
According to Clinical.Site data, the most researched conditions in "Studienpraxis Urologie" are
"Prostate Cancer" (7 trials), "Prostatic Neoplasms" (5 trials), "Prostate Cancer Metastatic" (4 trials), "Metastatic Castration Resistant Prostate Cancer" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Studienpraxis Urologie" in a lesser frequency.
Clinical Trials Intervention Types at Studienpraxis Urologie
Most popular intervention types in "Studienpraxis Urologie" are "Drug" (28 trials), "Biological" (9 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Prednisone" (6 trials), "Pembrolizumab" (4 trials), "Docetaxel" (3 trials) and "Rucaparib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Studienpraxis Urologie
The vast majority of trials in "Studienpraxis Urologie" are
24 trials for "Male" genders and 7 trials for "All" genders.
Clinical Trials Status at Studienpraxis Urologie
Currently, there are NaN active trials in "Studienpraxis Urologie".
undefined are not yet recruiting,
9 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Studienpraxis Urologie,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Studienpraxis Urologie, 2 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".